Free Trial
Ends Tomorrow! Last Chance to Get MarketBeat All Access at $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ACH
Accendra Health
$0.23
+12.9%		$0.75
$0.19
▼
$5.38
$17.64M1.571.22 million shs1.26 million shs
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$122.18
+0.8%		$116.82
$87.95
▼
$124.43
$2.28B0.83233,108 shs312,143 shs
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
$0.25
+7.1%		$0.44
$0.23
▼
$50.00
$3.32MN/A402,975 shs141,224 shs
InnovAge Holding Corp. stock logo
INNV
InnovAge
$9.10
-0.2%		$9.90
$3.93
▼
$12.64
$1.24B0.15377,313 shs475,986 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ACH
Accendra Health
+12.29%+1.28%-64.24%-93.13%+22,939,900.00%
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
+0.78%+3.59%+9.18%+4.71%+1.37%
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
+7.08%-8.22%-39.36%-38.17%+24,799,900.00%
InnovAge Holding Corp. stock logo
INNV
InnovAge
-0.22%-0.44%+2.36%-21.55%+79.13%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ACH
Accendra Health
$0.23
+12.9%		$0.75
$0.19
▼
$5.38
$17.64M1.571.22 million shs1.26 million shs
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$122.18
+0.8%		$116.82
$87.95
▼
$124.43
$2.28B0.83233,108 shs312,143 shs
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
$0.25
+7.1%		$0.44
$0.23
▼
$50.00
$3.32MN/A402,975 shs141,224 shs
InnovAge Holding Corp. stock logo
INNV
InnovAge
$9.10
-0.2%		$9.90
$3.93
▼
$12.64
$1.24B0.15377,313 shs475,986 shs
7 Stocks to Buy Before the Robotics Revolution Cover
7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ACH
Accendra Health
+12.29%+1.28%-64.24%-93.13%+22,939,900.00%
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
+0.78%+3.59%+9.18%+4.71%+1.37%
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
+7.08%-8.22%-39.36%-38.17%+24,799,900.00%
InnovAge Holding Corp. stock logo
INNV
InnovAge
-0.22%-0.44%+2.36%-21.55%+79.13%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ACH
Accendra Health
1.60
Reduce$1.50553.88% Upside
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
2.55
Moderate Buy$129.335.85% Upside
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
2.00
Hold$5.001,916.13% Upside
InnovAge Holding Corp. stock logo
INNV
InnovAge
1.75
Reduce$10.5015.38% Upside

Current Analyst Ratings Breakdown

Latest INNV, AIDX, ACH, and ADUS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/5/2026
ACH
Accendra Health
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeHold ➝ Strong Sell
9/28/2026
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$137.00
9/24/2026
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold (C) ➝ Hold (C+)
9/14/2026
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeMarket Outperform ➝ Neutral
9/14/2026
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$125.00
9/14/2026
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeBuy ➝ Neutral$140.00 ➝ $125.00
9/9/2026
InnovAge Holding Corp. stock logo
INNV
InnovAge
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOverweight$13.00 ➝ $14.00
8/21/2026
InnovAge Holding Corp. stock logo
INNV
InnovAge
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeSector Weight ➝ Overweight$13.00
8/13/2026
InnovAge Holding Corp. stock logo
INNV
InnovAge
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (D-)
8/13/2026
ACH
Accendra Health
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetNeutral$4.50 ➝ $1.50
8/11/2026
ACH
Accendra Health
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price TargetOutperform ➝ Neutral$1.50
(Data available from 10/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ACH
Accendra Health
$2.65B0.01$3.82 per share0.06($5.96) per share-0.04
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$1.42B1.60$6.51 per share18.76$58.72 per share2.08
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
$2.05M1.62N/AN/AN/A∞
InnovAge Holding Corp. stock logo
INNV
InnovAge
$989.71M1.25$0.14 per share66.90$1.76 per share5.17
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ACH
Accendra Health
-$1.10B-$3.91N/A2.55N/A-11.41%-4.02%0.70%N/A
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$95.91M$5.7021.4418.021.737.13%9.96%7.62%11/3/2026 (Confirmed)
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
-$3.74M-$0.54N/AN/AN/AN/AN/AN/AN/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
-$2.54M-$0.02N/A18.96N/A-0.26%-1.03%-0.47%11/3/2026 (Estimated)

Latest INNV, AIDX, ACH, and ADUS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/3/2026Q3 2026
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$1.79N/AN/AN/A$388.72 millionN/A
11/3/2026Q1 2027
InnovAge Holding Corp. stock logo
INNV
InnovAge
$0.0859N/AN/AN/A$257.23 millionN/A
9/8/2026Q4 2026
InnovAge Holding Corp. stock logo
INNV
InnovAge
$0.0747$0.06-$0.0147-$0.06$238.33 million$261.95 million
8/14/2026Q2 2026
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
N/A-$0.26N/A-$0.26N/A$0.73 million
8/10/2026Q2 2026
ACH
Accendra Health
-$0.13-$0.19-$0.06-$1.16N/A$613.23 million
8/3/2026Q2 2026
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
$1.70$1.73+$0.03$1.49$376.24 million$377.41 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ACH
Accendra Health
$0.1043.59%N/AN/A N/A
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
N/AN/AN/AN/AN/A
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
N/AN/AN/AN/AN/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ACH
Accendra Health
N/A
0.41
0.30
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
0.05
1.69
1.69
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
N/A
1.99
1.95
InnovAge Holding Corp. stock logo
INNV
InnovAge
0.23
1.05
1.05

Institutional Ownership

CompanyInstitutional Ownership
ACH
Accendra Health
N/A
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
95.35%
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
N/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
12.26%

Insider Ownership

CompanyInsider Ownership
ACH
Accendra Health
2.29%
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
4.10%
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
29.80%
InnovAge Holding Corp. stock logo
INNV
InnovAge
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
ACH
Accendra Health
6,50076.91 million75.14 millionOptionable
Addus HomeCare Corporation stock logo
ADUS
Addus HomeCare
50,65918.67 million17.91 millionOptionable
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
1413.37 million9.38 millionN/A
InnovAge Holding Corp. stock logo
INNV
InnovAge
2,500136.46 million135.09 millionOptionable

Recent News About These Companies

InnovAge (INNV) Set to Release Earnings on Tuesday
October 27 at 8:40 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/upcoming-innovage-innv-set-to-release-earnings-on-tuesday-2026-10-27/
InnovAge (NASDAQ:INNV) Insider Nicole Damato Sells 3,402 Shares of Company Stock
October 27 at 4:22 AM  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-innv-insider-buying-and-selling-2026-10-27/
Insider Selling: InnovAge (NASDAQ:INNV) Insider Sells 3,402 Shares of Stock
October 26 at 5:07 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-insider-selling-innovage-nasdaq-innv-insider-sells-3402-shares-of-stock-2026-10-26/
InnovAge (NASDAQ:INNV) Major Shareholder Sells $13,875,000.00 in Stock
October 24, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-innv-insider-buying-and-selling-2026-10-24/
InnovAge (NASDAQ:INNV) Stock: Insider Carson Anderson & Stow Welsh Sells 1,500,000 Shares
October 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-innovage-nasdaq-innv-stock-insider-carson-anderson-stow-welsh-sells-1500000-shares-2026-10-23/
InnovAge (NASDAQ:INNV) Major Shareholder Sells 1,500,000 Shares of Company Stock
October 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-innovage-nasdaq-innv-major-shareholder-sells-1500000-shares-of-company-stock-2026-10-23/
InnovAge Holding Corp. Announces Virtual Annual Meeting on December 3 with Four Key Director Votes
October 23, 2026  |  kalkinemedia.comK
InnovAge Holding Corp. ($INNV) CEO 2026 Pay Revealed
October 22, 2026  |  quiverquant.comQ
InnovAge : Leaders Share PACE Expertise and Innovation at National PACE Association Conference
October 22, 2026  |  marketscreener.comM
InnovAge to Announce Fiscal First Quarter 2027 Financial Results and Host Conference Call Tuesday, November 3, 2026
October 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/20/3384311/0/en/innovage-to-announce-fiscal-first-quarter-2027-financial-results-and-host-conference-call-tuesday-november-3-2026.html
InnovAge (NASDAQ:INNV) Downgraded by Wall Street Zen to "Buy"
October 18, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31129459
InnovAge (NASDAQ:INNV) Stock Rating Cut to "Buy" at Wall Street Zen
October 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-innovage-nasdaq-innv-stock-rating-cut-to-buy-at-wall-street-zen-2026-10-18/
Wall Street Zen upgrades InnovAge stock to strong-buy
October 15, 2026  |  ad-hoc-news.deA
InnovAge Holding Corp. (NASDAQ:INNV) Stock Short Interest Report for September
October 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/options-innovage-holding-corp-nasdaq-innv-stock-short-interest-report-for-september-2026-10-13/
InnovAge (NASDAQ:INNV) Upgraded at Wall Street Zen
October 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-innovage-nasdaq-innv-upgraded-at-wall-street-zen-2026-10-10/
InnovAge (NASDAQ:INNV) Sees Strong Trading Volume - What's Next?
October 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-innovage-nasdaq-innv-sees-strong-trading-volume-whats-next-2026-10-08/
InnovAge prices 10 million shares at USD 9.25 for InnovAge stock
October 5, 2026  |  ad-hoc-news.deA
InnovAge stock gained 1.82 percent after strong fiscal results
October 4, 2026  |  ad-hoc-news.deA
InnovAge (NASDAQ:INNV) Insider Sells $207,181.80 in Stock
September 30, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-innv-insider-buying-and-selling-2026-09-30/
InnovAge (NASDAQ:INNV) Stock: Insider Nicole Damato Sells 23,814 Shares
September 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-innovage-nasdaq-innv-stock-insider-nicole-damato-sells-23814-shares-2026-09-29/
Insider Selling: InnovAge (NASDAQ:INNV) Major Shareholder Sells 10,000,000 Shares of Stock
September 29, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-innv-insider-buying-and-selling-2026-09-29/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Digital screen displays a red candlestick stock chart trending downward, illustrating a declining market against a city skyline.
3 Stocks Chopped in Half: Why These Drops May Be Structural, Not a Dip
By Dan Schmidt | October 11, 2026
Palantir, ServiceNow and AMD: 3 AI Stocks Rebuilding After Brutal Pullbacks
Down 50% and Climbing Again: 3 AI Stocks Rebuilding After Brutal Pullbacks
By Bridget Bennett | October 1, 2026
Rows of server racks with blue network cables in a data center housing computing infrastructure.
3 AI Winners, 3 Very Different Paths to Higher Margins
By Dan Schmidt | October 3, 2026
Close-up of computer chips on a circuit board with a candlestick stock chart overlay in the background.
AI Uncertainty Is Rising, But These 3 Chip ETFs Still Have Momentum
By Nathan Reiff | September 30, 2026
Declining red candlestick stock chart with a downward trend line beside the text "Insider Selling".
Insiders Are Selling These 3 Stocks, Should You?
By Nathan Reiff | October 5, 2026

Accendra Health NYSE:ACH

$0.23 +0.03 (+12.95%)
As of 10/28/2026 03:58 PM Eastern

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

Addus HomeCare stock logo

Addus HomeCare NASDAQ:ADUS

$122.18 +0.94 (+0.78%)
Closing price 10/28/2026 04:00 PM Eastern
Extended Trading
$122.12 -0.06 (-0.05%)
As of 10/28/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

20/20 Biolabs stock logo

20/20 Biolabs NASDAQ:AIDX

$0.25 +0.02 (+7.08%)
Closing price 10/28/2026 04:00 PM Eastern
Extended Trading
$0.24 -0.01 (-2.82%)
As of 04:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

We develop and commercialize AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. We offer two families of lab tests, both under our OneTest brand: (i) OneTest for Cancer, a multi-cancer early detection, or MCED, blood test which has been our primary commercial focus and source of revenues since we wound down our COVID-19 testing business, and (ii) OneTest for Longevity, which measures inflammatory biomarkers, that we expect to launch in the first half of 2026. Both tests are run in our CAP (College of American Pathologists) accredited, CLIA (Clinical Laboratory Improvement Amendments) licensed laboratory in Gaithersburg, MD. That laboratory also hosts our Clinical Laboratory Innovation Accelerator, or CLIAx, which we believe is the country’s first shared CLIA laboratory for overseas diagnostics start-ups seeking to launch novel lab tests in the U.S. without the expense of establishing and operating their own, independent lab. As noted above, during the COVID-19 pandemic, we also provided COVID-19 viral testing using polymerase chain reaction, or PCR, analytical equipment in our clinical laboratory. Our legacy business also includes a pioneering field test kit for screening suspicious powders for bioterror agents known as BioCheck. As of the date of this prospectus, we generate revenue from three sources: OneTest for Cancer (primarily as a lab test in the U.S. but we also license our algorithms to overseas labs), BioCheck and from our CLIAx. For each of the nine months ended September 30, 2025 and 2024, sales of OneTest for Cancer accounted for approximately 87% of our revenues, sales of BioCheck accounted for approximately 9% of our revenues, and our CLIAx accounted for approximately 4% of our revenues. For the years ended December 31, 2024 and 2023, sales of OneTest for Cancer accounted for approximately 85% and 65% of our revenues, respectively, sales of BioCheck accounted for approximately 10% and 13% of our revenues, respectively, our CLIAx accounted for approximately 5% and 4% of our revenues, respectively, and COVID-19 testing accounted for approximately 0% and 18% of our revenues, respectively. Our principal executive offices are located in Gaithersburg, MD.

InnovAge stock logo

InnovAge NASDAQ:INNV

$9.10 -0.02 (-0.22%)
Closing price 10/28/2026 04:00 PM Eastern
Extended Trading
$9.10 0.00 (-0.05%)
As of 10/28/2026 04:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas